Azacitidine and Imbruvica drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azacitidine (azacitidine) and Imbruvica (ibrutinib). Common drug interactions include acute myeloid leukaemia among females and acute myeloid leukaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Azacitidine and Imbruvica. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Azacitidine?

Azacitidine has active ingredients of azacitidine. eHealthMe is studying from 17,184 Azacitidine users. Check the latest studies of Azacitidine.

What is Imbruvica?

Imbruvica has active ingredients of ibrutinib. It is often used in chronic lymphocytic leukemia (cll). eHealthMe is studying from 70,020 Imbruvica users. Check the latest studies of Imbruvica.

On Jul, 28, 2026

11 people who take Azacitidine and Imbruvica together, and have interactions are studied.

Azacitidine and Imbruvica drug interactions.

What are the common drug interactions of Azacitidine and Imbruvica, by gender? *:

female:

Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Bacteraemia (presence of bacteria in the blood)
Fungal sepsis (whole body infection by fungus)
Fusobacterium infection (bacterial infection)
Immunodeficiency
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina)
Mucosal inflammation (infection of mucous membrane)
Oesophageal dilatation (enlarged oesophagus)
Oesophagitis (inflammation of oesophagus)

male:

Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Neutropenia (an abnormally low number of neutrophils)
Fatigue (feeling of tiredness)
Febrile neutropenia (fever with reduced white blood cells)
Haemoglobin decreased
Hypersomnia (excessive daytime sleepiness (eds))
Injection site pain
Lip swelling
Oesophagitis (inflammation of oesophagus)
Pneumonia fungal

What are the common drug interactions of Azacitidine and Imbruvica, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Neutropenia (an abnormally low number of neutrophils)
Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina)
Mucosal inflammation (infection of mucous membrane)
Oesophageal dilatation (enlarged oesophagus)
Oesophagitis (inflammation of oesophagus)
Procedural haemorrhage (procedural bleeding)
Procedural hypotension
Pulmonary embolism (blockage of the main artery of the lung)
Septic embolus (a type of embolism that is infected with bacteria)

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 7 people, 63.64%
Diffuse Large B-Cell Lymphoma Stage Iv (cancer of b cells, a type of white blood cell-stage iv): 7 people, 63.64%
Diffuse Large B-Cell Lymphoma Recurrent (recurrent cancer of b cells, a type of white blood cell): 6 people, 54.55%
Acute Myelomonocytic Leukaemia (cancer of the blood-forming organs): 5 people, 45.45%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 36.36%
Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 1 person, 9.09%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Azacitidine and Imbruvica?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously